Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies David E. I. Pyott files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Yvonne Greenstreet - $20.98M of ALNY open-market activity in the last 12 months
- Kevin Joseph Fitzgerald - $9.34M of ALNY open-market activity in the last 12 months
- Colleen F. Reitan - $8.42M of ALNY open-market activity in the last 12 months
- Pushkal Garg - $7.58M of ALNY open-market activity in the last 12 months
- Jeffrey V. Poulton - $3.94M of ALNY open-market activity in the last 12 months
- Bobak R. Azamian - $3.31M of TARS open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is David E. I. Pyott?
David E. I. Pyott is a corporate insider, tracked as Director of Tarsus Pharmaceuticals, Inc. (TARS). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has David E. I. Pyott submitted recently?
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Has David E. I. Pyott been buying or selling stock?
Recorded transactions: 0 open-market purchases and 5 open-market sales ($1.15M) across all tracked filings.
Where can I see all of David E. I. Pyott's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow David E. I. Pyott and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
